ArticleFrontiers in oncology2025
Integration of intratumoral/peritumoral radiomics and deep learning for predicting overall survival in non-small cell lung cancer patients: a multicenter study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Radiomic prediction of early progression at 2 years post-treatment in patients with resectable rectal cancer based on rectal tumor and mesentery characteristics: a two-center study.Journal of gastrointestinal oncology · 2026Article
- An exploratory study on whole-lung radiomics features from computed tomography for prognostic prediction in non-small cell lung cancer with concurrent chemoradiotherapy.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prognostic assessment of non-small cell lung cancer (NSCLC) relies on TNM staging, yet tumor heterogeneity limits its accuracy. This study aimed to develop a model for improving the prediction of overall survival (OS) in NSCLC patients receiving radiotherapy, which integrated intratumoral/peritumoral radiomics features and 3D deep learning (DL) features. Methods: A total of 303 NSCLC patients from three centers were retrospectively enrolled. Radiomics features were extracted from intratumoral and 3/6/9 mm peritumoral regions on CT scans. A network named 3D-SE-ResNet was proposed to extract DL features. Lasso-Cox and principal component analysis (PCA) were used to integrate multidimensional features to establish a combined model. Performance was evaluated via the concordance index (C-index) and area under the curve (AUC). Survival differences were visualized through Kaplan-Meier curves. Results: The 6 mm expansion peritumoral radiomics features analysis showed the best performance (C-index: 0.63). The DL features outperformed the radiomics features (C-index: 0.74 vs 0.63). The combined model achieved the highest accuracy (C-index: 0.77/0.73 across datasets). K-M analysis confirmed significant survival differences (log-rank P < 0.001). Conclusion: The combined model integrates intratumoral/peritumoral radiomics features and 3D DL features and effectively predicts the OS of NSCLC patients, offering a novel tool for personalized radiotherapy strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.